CIK 0000886744
- Large accelerated filer
GERON CORP
Sign in to watch- Ticker
- GERN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 752287752
- Phone
- +1 650-473-7700
- Business address
- 919 EAST HILLSDALE BOULEVARD, SUITE 250, FOSTER CITY, CA, 94404
- Former names
- GERON CORPORATION
- Open-market buys, last 90 days
- $62,105
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-09 | SCARLETT JOHN A Chairman, President and CEO | Option exercise | +446,666 | $1.50 | $670K | 446,666 |
| 2023-02-09 | SCARLETT JOHN A Chairman, President and CEO | Sale | −446,666 | $3.03 | $1.4M | 0 |
| 2023-02-09 | SCARLETT JOHN A Chairman, President and CEO | Option exercise · Employee Stock Option (right to buy) | −446,666 | 0 | ||
| 2023-02-08 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Option exercise | +400,000 | $1.51 | $604K | 474,588 |
| 2023-02-08 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Sale | −400,000 | $3.08 | $1.2M | 74,588 |
| 2023-02-08 | Bloom Olivia Kyusuk EVP, Chief Financial Officer | Option exercise · Employee Stock Option (right to buy) | −400,000 | 0 | ||
| 2023-02-08 | SCARLETT JOHN A Chairman, President and CEO | Option exercise | +446,666 | $1.50 | $670K | 446,666 |
| 2023-02-08 | SCARLETT JOHN A Chairman, President and CEO | Sale | −446,666 | $3.08 | $1.4M | 0 |
| 2023-02-08 | SCARLETT JOHN A Chairman, President and CEO | Option exercise · Employee Stock Option (right to buy) | −446,666 | 0 | ||
| 2023-01-13 | EASTHAM KARIN Director | Option exercise | +35,000 | $1.10 | $39K | 109,047 |
| 2023-01-13 | EASTHAM KARIN Director | Option exercise · Stock Options (right to buy) | −35,000 | 0 | ||
| 2022-12-30 | Kapur Anil EVP, Corp Strategy & CCO | Grant or award | +6,021 | $1.11 | $7K | 53,216 |
| 2022-12-30 | Spiegel Robert J. Director | Grant or award | +2,970 | 151,693 | ||
| 2022-09-30 | Spiegel Robert J. Director | Grant or award | +3,071 | 148,723 | ||
| 2022-09-12 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Option exercise | +2,000 | $1.70 | $3K | 2,000 |
| 2022-09-12 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Option exercise | +232,719 | $1.70 | $396K | 234,719 |
| 2022-09-12 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Option exercise · Employee Stock Option (right to buy) | −2,000 | 65,281 | ||
| 2022-09-12 | GRETHLEIN ANDREW J EVP, Chief Operating Officer | Option exercise · Employee Stock Option (right to buy) | −232,719 | 0 | ||
| 2022-09-07 | McDonald John F Director | Grant or award · Stock Options (right to buy) | +200,000 | 200,000 | ||
| 2022-07-08 | Feller Faye EVP, Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +120,000 | 120,000 |
Page 8 of 15 · 291 trades